• Translating regulatory expectations into actionable QMS strategies to de-risk commercial manufacturing assessments
• Transforming legacy quality systems to enable advanced biotechnologies and accelerate product lifecycle management
• Leveraging external advocacy and industry collaborations to influence and adapt to emerging Regulatory tools and compliance standards
• Selecting facilities and implementing control and oversight strategies with regulatory assessment criteria to ensure rapid approval